FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX

By

-- CSL (ASX:CSL) led losses on the Australian bourse so far this year at AU$23.2 billion, while ResMed (ASX:RMD) and Cochlear (ASX:COH) followed with losses of AU$10.6 billion, the Australian Financial Review reported Monday, citing Global X ETFs.

Negative performing companies on the S&P/ASX 200 index collectively wiped out over AU$217 billion, said Marc Jocum, senior product and investment strategist at Global X ETFs.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Applied BioCode Unit Gets US FDA Nod for Respiratory Pathogen Panel

Applied BioCode's (TPE:6598) US unit has secured a 510(k) clearance from the U.S. FDA for its respiratory pathogen panel, according to a Monday Taiwan Exchange filing.The approval allows the panel to be used with the BioCode MDx 3000 system alongside Thermo Fisher Scientific's KingFisher extraction platform, adding to existing compatibility with systems from bioMérieux and Roche.The company said the clearance enables sales of the combined solution in the US, offers labs greater flexibility in extraction systems, and is expected to support its business and financial performance.

$TPE:6598
Asia

Qingling Motors Signs Repurchase Deal for 10 New Energy Vehicles

Qingling Motors (HKG:1122) signed repurchase agreements with a batch of dealers covering 10 new energy vehicles, according to a Thursday Hong Kong bourse filing.Shares of the firm were up nearly 5% in late morning trade on Monday.The maximum aggregate repurchase price under the deal is estimated at 2.1 million yuan, to be funded with internal resources, the filing said.The arrangement is part of Qingling's shift toward a finance lease model to boost sales of its new energy commercial vehicles.

$HKG:1122
Research

Research Alert: Oil & Gas E&p: Uae Departure From Opec Should Have A Long Fuse

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:The UAE departed OPEC on Friday, removing the cartel's third-biggest member with 3.64 mmb/d crude production, trailing only Iraq (4.50 mmb/d) and Saudi Arabia (10.40 mmb/d). The departure gives the UAE flexibility to boost production beyond current quotas, though it remains constrained by Persian Gulf blockades limiting tanker traffic through the Strait of Hormuz. We think the impact is likely a 2027 event, as the UAE exports 2.75 mmb/d but its Habshan-Fujairah Pipeline only handles 1.5 mmb/d, making incremental volumes dependent on Strait transit. The departure could enhance crude oil volatility for 2026-2027. We think 2026 will see considerable scarcity, benefiting E&Ps with spot exposure over the next two quarters while prices stay high. We see high potential for an oil price debacle in 2027 when more crude reaches markets, coupled with economic toll from nosebleed prices. Even U.S.-centric firms like FANG remain price-takers exposed to global crude pricing.

$FANG